These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12757728)

  • 41. Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.
    Gharagozloo P; Lazareno S; Miyauchi M; Popham A; Birdsall NJ
    J Med Chem; 2002 Mar; 45(6):1259-74. PubMed ID: 11881995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cooperative interactions at M2 muscarinic acetylcholine receptors: structure/activity relationships in stepwise shortened bispyridinium- and bis(ammonio)alkane-type allosteric modulators.
    Gilsbach R; Grossmüller M; Alptüzün V; Erciyas E; Tränkle C; Holzgrabe U; Mohr K
    Neurochem Res; 2003 Apr; 28(3-4):667-73. PubMed ID: 12675159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 6H,13H-Pyrazino[1,2-a;4,5-a']diindole analogs: probing the pharmacophore for allosteric ligands of muscarinic M2 receptors.
    Zlotos DP; Tränkle C; Abdelrahman A; Gündisch D; Radacki K; Braunschweig H; Mohr K
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1481-5. PubMed ID: 16387499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
    Tränkle C; Andresen I; Lambrecht G; Mohr K
    Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular rigidity and potency of bispyridinium type allosteric modulators at muscarinic M2-receptors.
    Tränkle C; Elis K; Wiese M; Mohr K
    Life Sci; 1997; 60(22):1995-2003. PubMed ID: 9180353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Competition between positive and negative allosteric effectors on muscarinic receptors.
    Proska J; Tucek S
    Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.
    Lanzafame A; Christopoulos A; Mitchelson F
    Eur J Pharmacol; 2001 Mar; 416(3):235-44. PubMed ID: 11290374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors.
    Proska J; Tucek S
    Eur J Pharmacol; 1996 Jun; 305(1-3):201-5. PubMed ID: 8813554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevation of ligand binding to muscarinic M(2) acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators.
    Raasch A; Scharfenstein O; Tränkle C; Holzgrabe U; Mohr K
    J Med Chem; 2002 Aug; 45(17):3809-12. PubMed ID: 12166953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic development of high affinity bis(ammonio)alkane-type allosteric enhancers of muscarinic ligand binding.
    Muth M; Bender W; Scharfenstein O; Holzgrabe U; Balatkova E; Tränkle C; Mohr K
    J Med Chem; 2003 Mar; 46(6):1031-40. PubMed ID: 12620079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease.
    Hernandez CC; Nascimento JH; Chaves EA; Costa PC; Masuda MO; Kurtenbach E; Campos DE Carvalho AC; Gimenez LE
    J Recept Signal Transduct Res; 2008; 28(4):375-401. PubMed ID: 18702010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM; Forde SC; Appadu BL; Lambert DG
    Eur J Pharmacol; 2007 Aug; 569(1-2):37-40. PubMed ID: 17588565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vinburnine decelerates [3H]N-methylscopolamine binding to recombinant human muscarinic M1-M4 acetylcholine receptors.
    Maksay G; Bíró T; Kiss B
    Eur J Pharmacol; 2004 Jan; 483(2-3):229-32. PubMed ID: 14729111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors.
    Bender W; Staudt M; Tränkle C; Mohr K; Holzgrabe U
    Life Sci; 2000 Mar; 66(18):1675-82. PubMed ID: 10809164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
    Tränkle C; Kostenis E; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84.
    Mohr M; Heller E; Ataie A; Mohr K; Holzgrabe U
    J Med Chem; 2004 Jun; 47(12):3324-7. PubMed ID: 15163212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
    Christopoulos A; Mitchelson F
    Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.
    Lysíková M; Fuksová K; Elbert T; Jakubík J; Tucek S
    Br J Pharmacol; 1999 Jul; 127(5):1240-6. PubMed ID: 10455271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.